Get started
Author

Tapojyoti Sanyal

Observed name: Sanyal, Tapojyoti
ORCID: 0009-0005-2813-3205
Observed ORCID: 0009-0005-2813-3205
OpenAlex ID: A5037115995
Microplastics as emerging carcinogens: from environmental pollutants to oncogenic drivers
2025 · Sarvesh Kumar Mishra, Tapojyoti Sanyal, et al. · Molecular Cancer · 51
PDF
Anticancer Activity of Solvent Extracts of Hexogonia glabra against Cervical Cancer Cell Lines
2020 · Swapan Kumar Ghosh, Tapojyoti Sanyal, et al. · Asian Pacific Journal of Cancer Prevention · 14
PDF
Mycochemistry, antioxidant content, and antioxidant potentiality of the ethanolic extract of Pleurotus florida and its anti-cancerous effect on HeLa cancer cell line, and antitumor effect on HeLa-implanted mice.
2023 · Koushik Pandey, Swapan Kumar Ghosh, et al. · PubMed · 6
Anti-cancer property of Lenzites betulina (L) Fr. on cervical cancer cell lines and its anti-tumor effect on HeLa-implanted mice
2019 · Tapojyoti Sanyal, Swapan Kumar Ghosh · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2024 · Murali K. Mamidi, Sutapa Sinha, et al. · Clinical Cancer Research · 3
PDF
ANTIPROLIFERATIVE AND APOPTOTIC EFFECT OF ETHANOLIC AND METHANOLIC EXTRACT OF EDIBLE MUSHROOM Agaricus bisporus AGAINST CaSki CELL LINE OF CERVICAL CANCER
2019 · Ghosh, Swapan Kumar, Sanyal, Tapojyoti, et al. · PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY · 2
Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL
2026 · Mariana T. Mendez, Tapojyoti Sanyal, et al. · Leukemia
Supplementary Table S1 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Data from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Table S7 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S5 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Table S5 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S3 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S10 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S2 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S9 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Table S8 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S6 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S7 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Table S3 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Table S6 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S4 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Table S2 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S8 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Supplementary Figure S1 from Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy
2025 · Murali K. Mamidi, Sutapa Sinha, et al.
Works count: 27
Citation count: 82
H-index: 4
I10-index: 2
Year
Topic
Type